Oct 27, 2016
Maybne Pharma announces the U.S. launch of budesonide capsules in a 3 mg dose. Budesonide is a generic alternative used as a treatment for patients with mild to moderate Crohn's disease.
Oct 18, 2016
Complete room and conditioner reduces drafts for smoking machine operations
Aug 03, 2016
The deal was part of the largest generic drug divestiture overseen by the Federal Trade Commission. It propels Mayne Pharma into the top 25 retail generic pharma companies in the U.S. and the second largest provider of generic oral contraceptives.
Oct 15, 2015
New unit requires no external ducting; no ceiling and little floor space needed
Sep 24, 2015
At an event celebrating the start of construction, Mayne Pharma shared new details about its planned $65-million, 126,000-square-foot oral-dose facility in Greenville, N.C. The new facility will double the company’s U.S. manufacturing capacity.
Aug 27, 2015
The company will invest $65 million to expand facilities and equipment at its site in Greenville, NC. Plans include greenfield construction of a new, 126,000-square-foot oral-dose commercial manufacturing facility, doubling US manufacturing capacity
Jul 13, 2015
Michael R. Mascarenas provides clients with quality formulation and process development of early-phase oral dosage drugs
Jul 06, 2015
Providing strategic oversight to a team of 100+ chemists, Keith Moore will support Metrics Contract Services with its rapidly growing client base and ever-evolving international quality compliance regulations.
May 04, 2015
The acquisition of Doryx® (doxycycline hyclate delayed-release tablets), indicated for the adjunctive treatment of severe acne*, spearheads the launch of Mayne Pharma’s U.S. Specialty Brands division, providing business platform for future growth
Apr 01, 2015
Already known and respected for its analytical capabilities, Metrics Contract Services has purchased new equipment that will speed testing for elemental impurities per new international guidelines